financetom
Business
financetom
/
Business
/
Ambrx Biopharma Shareholders Approve Johnson & Johnson Acquisition Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ambrx Biopharma Shareholders Approve Johnson & Johnson Acquisition Deal
Mar 6, 2024 11:11 AM

01:59 PM EST, 03/06/2024 (MT Newswires) -- Ambrx Biopharma ( AMAM ) said Wednesday that its shareholders have approved the proposed acquisition of the company by Johnson & Johnson ( JNJ ) .

Ambrx shareholders will receive $28.00 per share in cash with the deal, the company said. It expects to close the deal Thursday.

Price: 27.99, Change: +0.01, Percent Change: +0.04

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Levi Strauss ends lawsuit against Italy's Brunello Cucinelli over trademarked tab
Levi Strauss ends lawsuit against Italy's Brunello Cucinelli over trademarked tab
May 7, 2024
May 7 (Reuters) - Levi Strauss has ended its lawsuit accusing the Italian luxury fashion brand Brunello Cucinelli of infringing its familiar, trademarked rectangular pocket tab. Levi notified a federal judge in Oakland, California on Tuesday that it was dismissing the case with prejudice, meaning it cannot be brought again. Settlement talks began shortly after Levi sued in January. Neither...
Chord Energy Q1 Adjusted Earnings, Revenue Rise
Chord Energy Q1 Adjusted Earnings, Revenue Rise
May 7, 2024
05:18 PM EDT, 05/07/2024 (MT Newswires) -- Chord Energy ( CHRD ) reported Q1 adjusted earnings late Tuesday of $5.10 per diluted share, up from $4.49 a year earlier. Analysts surveyed by Capital IQ expected $4.80. Revenue for the quarter ended March 31 was $1.09 billion, up from $896.5 million a year earlier. Four analysts surveyed by Capital IQ expected...
Arcadium Lithium beats expectations on cost cuts despite weak pricing
Arcadium Lithium beats expectations on cost cuts despite weak pricing
May 7, 2024
May 7 (Reuters) - Arcadium Lithium ( ARLTF ), formed earlier this year with the merger of U.S. lithium miner Livent and Australia's Allkem, posted a drop in first-quarter profit on Tuesday due to a decline in prices for the metal used to make electric vehicle batteries, although results beat Wall Street's expectations on cost cuts. Global supplies for lithium...
Ero Copper's First-Quarter Profit Falls 25% Despite Higher Revenue but Tops Expectations
Ero Copper's First-Quarter Profit Falls 25% Despite Higher Revenue but Tops Expectations
May 7, 2024
05:17 PM EDT, 05/07/2024 (MT Newswires) -- Ero Copper ( ERO ) on Tuesday said its first-quarter adjusted profit fell 25% but topped expectations. The Brazilian copper and gold producer said its first-quarter adjusted profit, which excludes most one-time items, fell to US$16.8 million, or US$0.16 per share, from US$22.5 million, or US$0.24, in the year-prior quarter. The result topped...
Copyright 2023-2026 - www.financetom.com All Rights Reserved